Pharmaceutical

STAT+: U.K. trade group suspends Novo Nordisk for ‘seri...

A U.K. pharmaceutical industry trade group suspended Novo Nordisk for two years ...

STAT+: CRISPR? Nah. A new startup bets on an old approa...

Giving an old genome-editing tool a new twist, Seamless Therapeutics launches ba...

STAT+: Takeda autoimmune therapy shows effectiveness in...

‘We’ll look back and say that this was a bargain.’ Takeda reveals first data fro...